Comparison of three test media for antimicrobial susceptibility testing of bifidobacteria using the Etest method

International Journal of Antimicrobial Agents

Volumn 28, Issue 1, 2006, Pages 42-48

  Matto J ^a   Suihko, M L ^a   Saarela, M ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Antimicrobial susceptibility; Bifidobacterium; Etest; Test medium

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; CYSTEINE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LINCOSAMIDE; STREPTOGRAMIN; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIFIDOBACTERIUM; BRUCELLA BLOOD AGAR MEDIUM; CONTROLLED STUDY; ETEST METHOD; INTERMETHOD COMPARISON; LACTIC ACID BACTERIUM SUSCEPTIBILITY TEST MEDIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TRYPTICASE PHYTONE YEAST EXTRACT AGAR MEDIUM;

BIFIDOBACTERIUM; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS;

EID: 33745203036     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.010     Document Type: Article

References (26)

1. Gomes A.M.P., and Malcata F.X. Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci Technol 10 (1999) 139-157
2. Leahy S.C., Higgins D.G., Fitzgerald G.F., and van Sinderen D. Getting better with bifidobacteria. J Appl Microbiol 98 (2005) 1303-1315
3. Scardovi V. Genus Bifidobacterium. In: Sneath P.H.A., Mair H.S., Sharpe M.E., and Holt J.G. (Eds). Bergey's manual of systematic bacteriology (1986), Williams and Wilkins, Baltimore, MD 1418-1434
4. Saarela M., Mättö J., and Mattila-Sandholm T. Safety aspects of Lactobacillus and Bifidobacterium species originating from human oro-gastrointestinal tract or from probiotic products. Microb Ecol Health Dis 14 (2002) 233-240
5. Saarela M., Mogensen G., Fondén R., Mättö J., and Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84 (2000) 197-215
6. Fasoli S., Marzotto M., Rizzotti L., Rossi F., Dellaglio F., and Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 82 (2003) 59-70
7. Masco L., Huys G., de Brandt E., Temmerman R., and Swings J. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 102 (2005) 221-230
8. Andremont A. Commensal flora may play key role in spreading antibiotic resistance. ASM News 69 (2003) 601-607
9. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved Standard M11-A6. Vol. 24, No. 2. 6th ed. Wayne, PA: NCCLS; 2004.
10. Matteuzzi D., Crociani F., and Brigidi P. Antimicrobial susceptibility of Bifidobacterium. Ann Microbiol (Paris) 134A (1983) 339-349
11. Charteris W.P., Kelly P.M., Morelli L., and Collins J.K. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract. Lett Appl Microbiol 26 (1998) 333-337
12. Yazid A.M., Ali A.M., Shuhaimi M., Kalaivaani V., Rokiah M.Y., and Reezal A. Antimicrobial susceptibility of bifidobacteria. Lett Appl Microbiol 31 (2000) 57-62
13. Lim K.S., Huh C.S., and Baek Y.J. Antibiotic susceptibility of bifidobacteria. J Dairy Sci 76 (1993) 2168-2174
14. Kheadr E., Bernoussi N., Lacroix C., and Fliss I. Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. Int Dairy J 14 (2004) 1041-1053
15. Delgado S., Floréz A.B., and Mayo B. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract. Curr Microbiol 50 (2005) 202-207
16. Moubareck C., Gavini F., Vaugien L., Butel M.J., and Doucet-Populaire F. Antimicrobial susceptibility of bifidobacteria. J Antimicrob Chemother 55 (2005) 38-44
17. Aldridge K.E. Controversies in susceptibility testing of anaerobes. Clin Ther 10 (1987) 2-11
18. Huys G., D'Haene K.D., and Swings J. Influence of the culture medium on antibiotic susceptibility testing of food-associated lactic acid bacteria with the agar overlay disc diffusion method. Lett Appl Microbiol 34 (2002) 402-406
19. Klare I., Konstabel C., Müller-Bertling S., et al. Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, lactococci, pediococci, and bifidobacteria. Appl Environ Microbiol 71 (2005) 8982-8986
20. Mättö J., Malinen E., Suihko M.-L., Alander M., Palva A., and Saarela M. Genetic heterogeneity and functional properties of intestinal bifidobacteria. J Appl Microbiol 97 (2004) 459-470
21. Apajalahti J.H.A., Kettunen A., Nurminen P.H., Jatila H., and Holben W.E. Selective plating underestimates abundance and shows differential recovery of bifidobacterial species from human feces. Appl Environ Microbiol 69 (2003) 5731-5735
22. Citron D.M., Merriam C.V., Tyrrell K.L., Warren Y.A., Fernandez H., and Goldstein E.J.C. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob Agents Chemother 47 (2003) 2334-2338
23. Citron D.M., Ostovari M.I., Karlsson A., and Goldstein E.J.C. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 29 (1991) 2197-2203
24. Rasmussen B.A., Bush K., and Tally F.P. Antimicrobial resistance in anaerobes. Clin Infect Dis 24 Suppl. 1 (1997) S110-S120
25. Levy S.B., and Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10 12 Suppl. (2004) S122-S129
26. Roberts M.C. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 245 (2005) 195-203